Markets Business Research Reports Exclusives Economy & Finance Law & Policy

BQEdge | Why Lupin Has A Bitter Pill To Swallow

Darshan Mehta and Kannan Singaravelu share technical insights on which direction the stock of Lupin may move next.

BQ Desk
Employees walk along a path at the Lupin Ltd. pharmaceutical plant in Salcette, Goa, India (Photographer: Dhiraj Singh/Bloomberg)

BQEdge is specially curated for BQBlue subscribers. Every day this note will offer special equity market and stock-specific insights and flag select emerging trends in the tricky-to-trade derivatives market.

On Today's Edition

  • What do leading indicators suggest for Lupin's stock?

Watch | Pain Points For Lupin Stock

lock-gif
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
View Plans Subscribe
As a Subscriber you get
Full Access to
Full Access to
NDTV Profit App
Exclusives
Exclusives
Premium Stories
Access to
Access to
Bloomberg Stories
Curated
Curated
Newsletters
20,000+
20,000+
Research Reports
Priority Pass
Priority Pass
to Special Events
Minimal Ad
Minimal Ad
Experience
Members-Only
Members-Only
Rewards
Still Not convinced ?  Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
GET REGULAR UPDATES

RECOMMENDED FOR YOU

CFO Leaders: The Making Of Five Star CFOs 
timelogo Jan 14, 2021
Stocks Rise, Treasuries Fall on Stimulus Bets: Markets Wrap
timelogo Aug 19, 2019
Stocks End Record-Setting Week With Further Gains: Markets Wrap
timelogo Jul 15, 2019
The Mutual Fund Show: The Dos And Don’ts Of Online Investing
timelogo Apr 27, 2019

POPULAR

1
Oil Declines As US Steps Up Efforts To Secure A Truce In Gaza
2
Gold Steadies As Brisk US Inflation Quells Rate-Cut Expectations
3
Fidelity Sees Rupee As Top Carry Trade Pick On RBI's Tight Grip
4
ICICI Bank Q4 Results Review - Credit Growth Slowdown; NIMs Stable QoQ: IDBI Capital
5
Why Motilal Oswal Is Bullish On Telecom Stocks